PeterMD’s injectable testosterone page presents several prices expressed per month. Two of the lower rates belong to plans billed upfront, so the amount displayed beside the word monthly is not necessarily what leaves your account each month. That difference deserves attention before the plan becomes a budget.

This review uses the current injectable offer checked September 22, 2026, together with medical and FDA references. We did not complete checkout, enroll as a patient, or verify a personal prescription. The provider’s treatment descriptions and promotional promises are not independent evidence of results.

KEEP IN MIND

The useful bits.

  • The $79 and $109 monthly equivalents are tied to upfront 12- and six-month plans.
  • The checked injectable offer excludes Alabama and Idaho.
  • Resolve inconsistent monthly-plan totals and obtain the exact medication and terms.

Compare the rate with the amount due

The page lists $79 per month for a 12-month plan with a $948 total and $109 monthly for six months with a $654 total. The longer plans are described as billed upfront. It also displays a $139 monthly option. Keep the payment interval beside the rate when comparing it with another service.

There is inconsistent total-price text around the monthly offer on the checked page, including a $1,068 figure that does not reconcile with twelve payments of $139. We cannot resolve that by choosing whichever number looks most appealing. Request the actual amount due, renewal price, and governing terms in writing before paying.

Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions

The lowest advertised rate is not a complete personal quote

PeterMD describes prescription treatment and free shipping, but a headline does not establish all testing, supply, follow-up, or additional medication costs for your situation. Ask what the specific plan includes and which necessary services are purchased separately. A claim about provider access also does not measure appointment availability or support response time.

Use the cost planner after you have the relevant figures, and keep unresolved charges visible. The PeterMD versus AlphaMD comparison shows why similar payment tiers still need individual quotes. Do not assume a lower annual rate removes the risks of a longer financial commitment.

Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions

Check the state exclusion early

The injectable page marks the offer as unavailable in Alabama and Idaho. Readers elsewhere should still confirm the current clinical service and prescribing arrangements for their own location. We have not independently verified a complete state-by-state availability list or what happens when an enrolled patient moves.

Ask whether travel or a change of residence could affect appointments and continuing care. If the provider cannot presently supply the relevant service where you live, a price comparison is premature. Written confirmation of access is more useful than a general statement that healthcare is available online.

Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions

Understand what the ingredient name does and does not prove

The page identifies testosterone cypionate for the injectable offer. That does not establish the manufacturer, exact formulation, dispensing pharmacy, or approval status of the finished prescription a particular patient would receive. Ask for those details before assuming the product is the same as a named medicine you have used elsewhere.

Our approved-versus-compounded guide explains the distinction. Compounded preparations do not have FDA approval, even when their ingredient is familiar. General language about regulated care, US sourcing, or professional prescribing should not be converted into a claim that every finished medication is FDA-approved.

Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions · FDA: understanding the risks of compounded drugs

An intake form is not the diagnosis

Ask how the evaluating clinician connects your symptoms with laboratory findings and investigates the cause. Clinical guidance recommends consistently low testosterone with relevant symptoms or signs and repeat morning fasting confirmation. A convenient enrollment process cannot replace the medical work needed to decide whether treatment is appropriate.

The testing guide can help you prepare earlier results and questions. Mention fertility plans before prescribing, because exogenous testosterone can suppress sperm production. A product page’s energy, strength, or confidence promises do not guarantee that those changes will occur for you.

Sources: Endocrine Society: testosterone therapy clinical guidance

Ask about the plan after enrollment

Find out who orders follow-up tests, explains findings, and reviews symptoms and possible harms. Blood pressure and blood counts are among the issues to discuss with the clinician. The appropriate schedule depends on the individual and the prescription, not simply the payment term selected at checkout.

If you already receive TRT elsewhere, read the switching-provider guide. Ask whether existing records are acceptable and how prescribing responsibility would change. Do not cancel established care or assume a new service will duplicate your current prescription before the new clinician has evaluated the situation.

Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes · PeterMD: injectable testosterone plans, payment terms, and state exclusions

Resolve renewal and exit terms before committing

The longer-plan cards describe an option to renew monthly after the initial term. Ask how that option is exercised, what rate applies, and what obligations remain if treatment changes sooner. We did not verify the complete individual agreement or a universal refund entitlement from the public offer.

Our billing-flexibility shortlist treats those unanswered questions as part of the comparison. PeterMD’s published tiers provide a starting point, but they do not establish the cheapest full plan or the best clinical fit. The decision needs a clear quote and a medical rationale you understand.

Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions

Sources you can check

Provider pages describe commercial offers. Medical references provide context. Checked September 22, 2026; prices and availability can change.

  1. PeterMD: injectable testosterone plans, payment terms, and state exclusions
  2. FDA: understanding the risks of compounded drugs
  3. Endocrine Society: testosterone therapy clinical guidance
  4. FDA: 2025 testosterone labeling and blood pressure changes

Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.